Latest Competition News

Reef Casino Trust (ASX, RCT) has received a recommended off-market takeover offer from Iris Cairns Property Pty Ltd at $3.87 per unit, representing a significant premium over recent trading prices. The independent expert affirms the offer as fair and reasonable, with major unitholders supporting the bid subject to regulatory approvals.

Vinyl Group has finalized an equity conversion agreement with Songtradr, extinguishing nearly $2 million in liabilities and gaining full control of the Vinyl.com domain. This move strengthens the company’s balance sheet and sets the stage for its FY26 growth ambitions.

Eastern Resources Limited has secured a farm-in agreement to earn up to 80% interest in Queensland’s Marengo Gold Project, a historically rich goldfield with promising high-grade assays and multiple exploration targets.

Nyrada Inc. has announced successful Phase I trial results for its lead drug candidate Xolatryp, confirming safety and pharmacokinetics that pave the way for a Phase IIa trial targeting heart attack patients next year.

Pioneer Lithium has raised $750,000 through a well-supported placement featuring director participation and a board reshuffle, aiming to fuel exploration and project development.

Black Rock Mining has secured A$10 million through an equity placement to initiate early construction activities at its Mahenge Graphite Project in Tanzania, marking a pivotal step towards full project development.

EMVision Medical Devices launches a $2 million Share Purchase Plan offering shares at a 16.4% discount, bundled with free options exercisable at $3.40, aiming to bolster clinical and commercial milestones.

Critica Limited reports strong preliminary beneficiation results from its Jupiter rare earths project, achieving consistent ~95% mass rejection and a 6–10x uplift in rare earth grades. A closed-circuit pilot plant is now under construction to optimise recovery and advance product development.

Rent.com.au reports strong early success with its RentBond® loan product, doubling loan volumes in September and drawing down a second $1 million tranche from its $10 million funding facility with Eldium.

Synlait Milk Limited reports a modest profit turnaround in FY25 and announces a major sale of its North Island assets to Abbott, aiming to reduce debt and sharpen its focus on core operations.

Synlait has agreed to sell its North Island assets to global healthcare giant Abbott for approximately US$178 million, marking a strategic reset focused on debt reduction and operational simplification. The deal, expected to close by April 2026, positions Synlait to concentrate on its South Island operations and explore new growth avenues.

Bod Science Limited has reported a notable profit turnaround for FY2025, driven by medicinal cannabis sales growth, while navigating a complex Deed of Company Arrangement and a proposed backdoor listing with Biortica Agrimed Limited.